C R Boland
Overview
Explore the profile of C R Boland including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
103
Citations
4931
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Perez-Carbonell L, Sinicrope F, Alberts S, Oberg A, Balaguer F, Castells A, et al.
Br J Cancer
. 2015 Jun;
113(1):83-90.
PMID: 26035698
Background: Advances in early detection and treatment have improved outcomes in patients with colorectal cancer (CRC). However, there remains a need for robust prognostic and predictive biomarkers. We conducted a...
2.
Piazzi G, Selgrad M, Garcia M, Ceccarelli C, Fini L, Bianchi P, et al.
Br J Cancer
. 2013 Apr;
108(8):1750-6.
PMID: 23579212
Background: Aberrant activation of the canonical WNT signaling is a feature of colorectal cancer (CRC). Van-Gogh-like 2 (VANGL2) belongs to the non-canonical WNT pathway whose activation inhibits canonical WNT signaling....
3.
Lynch H, Lynch P, Lanspa S, Snyder C, Lynch J, Boland C
Clin Genet
. 2009 Aug;
76(1):1-18.
PMID: 19659756
More than one million patients will manifest colorectal cancer (CRC) this year of which, conservatively, approximately 3% (approximately 30,700 cases) will have Lynch syndrome (LS), the most common hereditary CRC...
4.
Goel A, Mittal A, Evstatiev R, Nemeth M, Kruis W, Stolte M, et al.
Aliment Pharmacol Ther
. 2009 Jun;
30(6):634-42.
PMID: 19558562
Background: Microsatellite instability (MSI) occurs in chronically inflamed colorectal tissue and may evolve to colitis-associated cancer. In vitro data suggest that mesalazine (5-ASA) improves MSI. Aim: To analyse the changes...
5.
Selgrad M, De Giorgio R, Fini L, Cogliandro R, Williams S, Stanghellini V, et al.
Gut
. 2008 Jul;
58(1):25-32.
PMID: 18593810
Background And Aims: Chronic idiopathic intestinal pseudo-obstruction (CIIP) is characterised by severe impairment of intestinal propulsive motility that mimics bowel obstruction. JC virus (JCV) is a polyomavirus that can infect...
6.
Boland C, Luciani M, Gasche C, Goel A
Gut
. 2005 Aug;
54(9):1321-31.
PMID: 16099799
No abstract available.
7.
Muller W, Burgart L, Krause-Paulus R, Thibodeau S, Almeida M, Edmonston T, et al.
Fam Cancer
. 2003 Oct;
1(2):87-92.
PMID: 14574003
Hereditary nonpolyposis colorectal cancer syndrome (HNPCC) is an autosomal dominant condition accounting for 2-5% of all colorectal carcinomas as well as a small subset of endometrial, upper urinary tract and...
8.
Tassone P, Tagliaferri P, Viscomi C, Palmieri C, Caraglia M, DAlessandro A, et al.
Br J Cancer
. 2003 Jun;
88(12):1971-8.
PMID: 12799645
Bisphosphonates (BPs) are an emerging class of drugs mostly used in the palliative care of cancer patients. We investigated the in vitro activity of the most potent antiresorptive BP, zoledronic...
9.
Tassone P, Tagliaferri P, Perricelli A, Blotta S, Quaresima B, Martelli M, et al.
Br J Cancer
. 2003 Apr;
88(8):1285-91.
PMID: 12698198
Germline mutations of the tumour suppressor gene BRCA1 are involved in the predisposition and development of breast cancer and account for 20-45% of all hereditary cases. There is an increasing...
10.